ABT vs MDRR · P/E 25, rev $44.33B vs P/E 3.1, rev $4.0M
Abbott Laboratories (ABT) versus Medalist Diversified Reit Inc (MDRR) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
Medalist Diversified Reit Inc (MDRR) is a real estate services company listed on US.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported MDRR revenue for 2026-06-30 was $4.0M. Net income was $8.5M. Revenue was up 83.8% from 2026-03-31 to 2026-06-30. MDRR currently screens at market cap $18.7M and trailing P/E 3.1.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. MDRR currently screens at market cap $18.7M and trailing P/E 3.1.
Not investment advice. Open the ABT and MDRR stock pages for the full models.
Not investment advice.